Abstract
Background
Characterization of allergic responses to cockroach (CR), a common aeroallergen associated with asthma, has focused mainly on IgE reactivity, but little is known about T cell responses, particularly in children. We conducted a functional evaluation of CR allergen‐specific T cell reactivity in a cohort of CR allergic children with asthma.
Methods
Peripheral blood mononuclear cells (PBMCs) were obtained from 71 children, with mild‐to‐moderate asthma who were enrolled in a CR immunotherapy (IT) clinical trial, prior to treatment initiation. PBMC were stimulated with peptide pools derived from 11 CR allergens, and CD4+ T cell responses assessed by intracellular cytokine staining.
Results
Highly heterogeneous responses in T cell reactivity were observed among participants, both in terms of the magnitude of cytokine response and allergen immunodominance. Reactivity against Bla g 9 and Bla g 5 was most frequent. The phenotype of the T cell response was dominated by IL‐4 production and a Th2 polarized profile in 54.9% of participants, but IFNγ production and Th1 polarization was observed in 25.3% of the participants. The numbers of regulatory CD4+ T cells were also highly variable and the magnitude of effector responses and Th2 polarization were positively correlated with serum IgE levels specific to a clinical CR extract.
Conclusions
Our results demonstrate that in children with mild‐to‐moderate asthma, CR‐specific T cell responses display a wide range of magnitude, allergen dominance, and polarization. These results will enable examination of whether any of the variables measured are affected by IT and/or are predictive of clinical outcomes.
Keywords: allergens, asthma, clinical immunology, cockroach, T cell
1. INTRODUCTION
Cockroach is a common allergen in urban and under‐resourced areas and a significant source of atopic morbidity worldwide, particularly among children and young adults. 1 , 2 , 3 The German cockroach (CR, Blattella germanica) is commonly associated with CR allergies in the United States with CR allergens being detected in 85% of homes in low‐income urban communities. 4 CR allergy has a high prevalence, and has long been established as a strong cause of asthma initiation and progression with early exposure leading to increased CR sensitization, asthma severity, and morbidity. 4 , 5 , 6 , 7 , 8
Several studies defined CR allergens based on IgE reactivity from sensitized individuals and correlated sensitization prevalence with severity of clinical symptoms. 3 , 9 , 10 , 11 , 12 T cells, and in particular type 2T helper cells, significantly contribute to the development of allergy and asthma 13 , 14 , 15 ; however, CR‐specific T cell responses have been characterized in less detail, 16 , 17 , 18 , 19 , 20 , 21 and very little information is available particularly for the population most impacted by CR allergies, namely urban and under‐resourced children.
In general, allergen‐specific T cell responses are often characterized following in vitro expansion steps 17 , 22 , 23 , 24 , 25 to account for their low frequency which may also alter the phenotype of responding T cells. 26 We and others previously demonstrated that allergen‐specific T cells can be detected ex vivo using a novel assay strategy with the combination of several T cell epitopes into pools. 24 , 27 , 28 , 29 This technique uses the upregulation of the activation markers such as CD154 (CD40L) as a read‐out for T cell reactivity and can be combined with intracellular cytokine staining (ICS) to further identify T cell phenotypes as well as polyfunctionality 24 , 27 , 30 and to improve the characterization of CR‐specific T cell responses.
Thirteen groups of German CR allergens have been defined based on IgE reactivity and are listed at the official allergen database maintained by the World Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub‐committee (www.allergen.org). 2 As in the case of other allergies (i.e., cat, mite, or mouse 24 , 27 , 31 , 32 ), certain allergens have been described as dominant for CR‐specific T cell responses. Those studies however were associated with certain limitations, such as testing a set of candidates derived from predicted epitopes from a more limited set of allergens, reliance on in vitro expansion and re‐stimulation steps, and most importantly they only addressed dominance in sensitized adults. 16 , 17 , 18
Here we characterized the patterns of T cell responses to 11 cockroach allergens in a cohort of children with CR sensitization and asthma with a median age of 12 years that were enrolled as potential participants in an IT clinical trial (CRITICAL) and before initiation of treatment. T cell responses for each individual allergen were assessed by conducting ex vivo assays directly from PBMC not pre‐stimulated with CR extract using pools of overlapping peptides spanning the entire protein sequence of the various CR allergens. The basal numbers of regulatory CD4+ T cells (Tregs) was also assessed, and compared with the magnitude of effector T cell responses. Additional correlation analyses were performed to examine the relationship of T cell responses to skin prick test and serological IgE responses 33 as well as to the Composite Asthma Severity Index (CASI) and its components. 34
2. METHODS
2.1. Study subjects
This cohort is part of an ongoing clinical trial CRITICAL (Cockroach Immunotherapy in Children and Adolescents; https://clinicaltrials.gov/ct2/show/NCT03541187). Subjects were enrolled if they were IgE sensitized to CR antigen (measured by skin prick testing and serum IgE) and were ages 8 through 17 with well‐controlled asthma (mild‐moderate persistent) at study entry (Table 1). Clinical characteristics and evaluation are detailed in the online supporting information. The study was approved via a central Institutional Review Board, the Western IRB (WIRB Tracking Number 20180698), the DAIT NIAID and NIH/IND# 17979 (Protocol ID#: ICAC‐28). All participants enrolled in this study provided written consent or provided assent with parental consent.
TABLE 1.
Participating donors | Sex (%) | Demographic subgroup (%) | Other variables | Age | CASI score a | Cockroach‐specific IgE (kUA/L) | SPT wheal size b (mm) |
---|---|---|---|---|---|---|---|
Total number n = 71 | 54.9% M 45.1% F | Black or African American (63.4) White (18.3) Other (18.3) | Range | 8–17 | 2–8 | 0.12–>100 | 3.0–17.5 |
Median | 12.0 | 4.0 | 2.8 | 6.0 | |||
Average | 12.0 | 3.7 | 23.5 | 6.9 | |||
Std deviation | 2.4 | 1.3 | 69.6 | 3.3 |
CASI stands for Composite Asthma Severity Index. Range of scores: 0 (least severe) to 20 (most severe) asthma.
SPT stands for skin prick test.
2.2. PBMC isolation
Peripheral blood mononuclear cells (PBMC) were isolated from whole blood by using CPT (cell preparation tubes) tubes according to the manufacturer's instructions (BD Vacutainer CPT tube with sodium heparin BD 362753, BD Biosciences) as detailed in the online supporting information.
2.3. Measurement of IgE, IgG, and IgG4 antibody and peptide synthesis
Cockroach‐specific IgE, IgG, and IgG4 antibody levels were measured in sera using a Thermo Fisher Scientific ImmunoCAP system (Phadia 250 Immunoassay Analyzer; Thermo Fisher Scientific) as explained in the online supporting information. Sequences of 11 major cockroach allergens were collected from UniProt. A strategy using 15mer peptides overlapping by 10 amino acids was selected to get the full coverage of all the allergens (Table S1). It is well established that epitopes bind to HLA‐class II molecules through a nine residues core, and are on average 14–16 residues in overall length. The peptide selection utilized in this manuscript and commonly utilized in other studies relies on the fact that ensures that each 9 “core” amino acids that bind to the MHC‐II groove is contained in at least one peptide. An alternative strategy would be to generate 15mers overlapping by 14 amino acids. Although more rigorous, this strategy would significantly increase the number of peptides to be generated and tested which was not feasible in light of the limited numbers of cells available to study. Peptides were purchased from A & A as crude material on a small (1 mg) scale.
2.4. Activation Induced Marker (AIM) assay and experimental design
Evaluations of T cell responses were based on previously described Activation Induced Marker (AIM) ex vivo assays, 30 , 35 , 36 utilizing the CD154 (CD40L) and CD137 (4‐1BB) markers, combined with intracellular cytokine staining (ICS), using the antibodies described in Table S2 and performed as detailed in the online supporting information. The cytokines IL‐4, IFNγ, and IL‐10 were included as representative of Th2, Th1, and Tr1/T Regulatory (Tregs) CD4 helper T cell subsets, respectively. 24 , 37 The phenotypic CD127 and CD25 Tregs markers were also included in the cytometry analysis panel 30 , 38 and the several T cell parameters determined as described in the supporting information.
2.5. Statistical analysis
Comparisons between cytokine responses were performed using the nonparametric two‐tailed, paired Wilcoxon test. Correlations between magnitude of response and polarization or between different cytokine production in each participant were performed using the Spearman's rank correlation coefficient test. No adjustment for multiple comparisons was performed. Pearson correlation test was used to compare the two different measurements of Tregs. Prism 8.0.1 (GraphPad) was used for these calculations. Values pertaining to significance and correlation coefficient (R) are noted in the respective figure, and P < 0.05 defined as statistically significant.
3. RESULTS
3.1. Study strategy
PBMC were obtained from 71 study participants enrolled from 11 clinical sites prior to allergen IT and cryopreserved for subsequent analysis (Figure 1a). To characterize the magnitude and polarization of allergen responses directed against Blatella germanica (Bla g) allergens, we tested sets of overlapping peptides, spanning the entire sequence of 11 different CR allergens, using Activation Induced Marker (AIM) assays, 30 , 35 , 36 combined with Intracellular Cytokine Staining (ICS; Figure 1b and see supporting information for more detail).
Figure 1c shows representative data for the detection of each cytokine. Three different donors where used for the different cytokine measurements. Specifically, IL‐4 response to Bla g 9, IFNγ response to Bla g 3, and IL‐10 response to Bla g 2 allergen peptide pool stimulation. Strong cytokine production was observed in response to the positive control (PMA/Ion) but not in response to the negative control (DMSO) or peptide pools from allergens not recognized for a particular donor. For each participant, individual IL‐4, IFNγ, and IL‐10 cytokine responses to each pool was summated to determine the total number of effector T cells (Teff; antigen‐specific CD154+ cells 24 , 30 ).
3.2. Overall magnitude and polarization of Bla g‐specific T cell responses
The overall magnitude of CD4+ T cell CR‐specific responses is shown in Figure 2a, where for each participant a bar represents the total cytokine response for all the different allergens combined. Each bar is further color coded to show which fraction of the response for each participant is accounted for IL‐4 (blue), IFNγ (red), or IL‐10 (green). The overall magnitude of baseline responses varied over approximately 2 logs across different subjects in the study cohort (ranging from 21 to 1198 cells per million of CD4+ T cells).
This large variation between participants was not the result of assay‐to‐assay variability, as demonstrated by specific controls utilized in the assays. More specifically, in each assay, we also included a PBMC aliquot from an adult volunteer with a moderate degree of cockroach allergy, who underwent apheresis to provide numerous cell aliquots available for use. As shown in Figure S1a, limited assay‐to‐assay variability was observed in repeated assays (n = 42) from the lowest to the highest response in the 3.3‐fold range, which is far less variable than variability observed within the participant cohort (57‐fold). Furthermore, as shown in Figure S1b, the variation in the percent of each cytokine for the control donor was calculated for each repeated assay. The response accounted predominantly for IL‐4 cytokine secretion and, the Th2 polarization (>50% of total response) was consistently observed in all technical repeats (n = 42). Lastly, no significant difference was observed in the magnitude of response as a function of the different clinical sites from which the subjects were enrolled (Figure S1c).
Overall, IL‐4 responses across the different participants were significantly larger than the IFNγ and IL‐10 responses, approximately 2‐fold and 4‐fold larger, respectively (Figure 2b). This was expected as all subjects in the study cohort were diagnosed with allergic asthma, and that a Th2 profile is a characteristic feature of allergic responses. 39 , 40 To visualize the nature and degree of polarization as a function of each individual participant, the same data were plotted in an alternative format (Figure 2c) where, for each participant, the percent of the total response to be ascribed to each of the three cytokines was plotted and grouped according with their polarization profile (>50% of total response). The responses in most participants (n = 39/71) were IL‐4 polarized (i.e., IL‐4 is the dominant cytokine produced), while only 18 and 3 participants were IFNγ and IL‐10 polarized, respectively. No clear polarization was noted for an additional 11 participants. Interestingly, an IFNγ and IL‐4 co‐dominant pattern was observed in 4 out of those 11 individuals.
The data in Figure 2a indicate that the most vigorous responses were also the most polarized toward IL‐4 production. Further analysis (Figure 2d) found that the total magnitude (total cytokine response) correlated with Th2 (IL‐4) responses (p < 0.0001; R = 0.59) and inversely correlated with Th1 (IFNγ) and IL‐10 producing cells (p = 0.0009; R = −0.38 and p < 0.0001; R = −0.53, respectively). These results suggest that stronger responses to CR allergens were more IL‐4 polarized, and that weaker responses were associated with IFNγ and/or IL‐10 production. Correlation between the different cytokine responses in each individual participant was also analyzed. As shown in 2, IFNγ and IL‐10 responses were highly correlated but IL‐4 did not correlate with IFNγ or IL‐10 responses. Further correlation analysis comparing the polyclonal T cell responses (PMA/Ion stimulation) and CR‐specific T cell responses was performed. As shown in Figure S3, CR‐specific immune responses in this study do not reflect the general immune responses at the individual donor level.
Lastly, in these experiments, we also included a previously described megapool of Bordetella pertussis (BP) epitopes. 41 Children in our cohort, based on their year of birth, are expected to have been vaccinated with the acellular pertussis (aP) vaccine which is associated with a predominantly Th2 response. 42 , 43 As expected, and shown in Figure S4a, BP responses in this cohort were Th2 polarized, with a median ratio of IL‐4/IFNγ cytokine response of 2.5 and significant participant‐to‐participant variability. The degree of Th2 polarization observed in the BP responses did not correlate with the degree of polarization observed in the CR responses (Figure S4b), suggesting that there are factors determining the degree of Th2 polarization that are antigen/allergen‐specific.
3.3. Bla g 9 and Bla g 5 are the most dominant allergens for T cell responses
Previous studies established that certain allergens are immunodominant (i.e., account for a larger fraction of the total response) 17 , 24 , 44 at the population level. However, more granular analyses also established that individual patterns of immunodominance are also detected, and the immunodominant antigens can vary from one individual to the next. 10 , 11 , 16
Accordingly, we first established which specific CR allergens would be dominant for T cell responses in the cohort of allergic CR‐sensitized children. Figure 3a shows the overall response directed against each allergen, calculated by summing, separately for each individual allergen, the responses observed in each individual participant. The Bla g 9 and Bla g 5 allergens were the most dominant, accounting for 38.8% and 11.1% of the total response. Other allergens were also recognized, albeit to a lower extent. When considering the individual types of immune responses Bla g 9 was by large the most dominant allergen of IL‐4 responses (52.1%), and Bla g 3 (16.0%) or Bla g 2 (14.5%) the most dominant allergens of IFNγ and IL‐10 cytokine responses, respectively (Figure 3a and Figure S5).
Next, the data were analyzed at a higher level of granularity to investigate which antigens would be more dominantly recognized for each of the subjects tested, and each participant was assigned to different immunodominance categories. In terms of total cytokine response (Figure 3b), a total of 19 participants recognized the Bla g 9 allergen as most dominant, while Bla g 5 was most dominant in 7 participants. Bla g 3 and Bla g 7 were dominant in 4 participants, and Bla g six in 3 participants. The other allergens were dominant in one and two participants each or none, and patterns of co‐dominance or no clear pattern of dominance were detected for 28 participants (Figure 3b).
3.4. Detection of basal levels of regulatory T cells
In the next series of experiments, we analyzed the number of Tregs at baseline in the absence of antigen stimulation. We defined baseline Tregs as the total number of CD137 + CD154‐ T cells detected at baseline, without any antigen stimulation. 30 As expected, Tregs defined as CD137+ were correlated with Tregs defined by the alternative markers CD4+CD25 + CD127low 38 , 45 (Figure 4a and 4b). There was substantial variation in the number of Tregs (total CD137+) among participants (Figure 4c), the number of CD137+ cells varing 90‐fold from 925 to 86,000 per million CD4+ T cells.
We hypothesized that the size of the baseline Treg population present in each individual might influence their capacity to mount an allergen‐specific T cell response following stimulation with the allergen‐derived peptide pools. There was a suggestion of an inverse correlation between the number of Tregs (CD137+ unstimulated cells) and the number of Teff (cytokine + CD154+ allergen‐stimulated cells), but this was not statistically significant (Figure 4d). We further observed to be the case in patients with IL‐4 but not IFNγ dominant responses (Figure S6).
3.5. Correlation of T cell responses with sera antibody titers to CR extract, SPT responses, and clinical presentation
We also tested whether T cell responses were associated with IgE, IgG, and IgG4 titers specific for CR as well as with the ratio between IgE/IgG4 responses. The results summarizing these analyses are shown in Table 2. A significant correlation was observed between IL‐4 responses or IL‐4 (Th2) polarization and IgE levels (p = 0.0003; R = 0.42 and p < 0.0001; R = 0.45, respectively) and to a less extent with total IgG but not IgG4. Conversely, IFNγ (Th1) and IL‐10 polarization showed an inverse correlation with the IgE titers (p = 0.0044; R = −0.33 and p = 0.0013; R = −0.37, respectively). The same results were noted in regards to the correlation with the IgE/IgG4 ratios. In addition, as shown in Table 2, the total magnitude of responses positively correlated with IgE titers or the IgE/IgG4 ratios (p = 0.0082; R = 0.31 and p = 0.0071; R = 0.32, respectively), and no associations were observed for Treg frequencies.
TABLE 2.
Spearman r | IgE Ext (RU a ) | IgG Ext (RU a ) | IgG4 Ext (RU a ) | Ratio IgE/IgG4 |
---|---|---|---|---|
Total magnitude of responses (CD154) | ||||
R | 0.31 | 0.15 | 0.14 | 0.32 |
P value | 0.0082 | 0.2125 | 0.2542 | 0.0071 |
IL‐4 responses (CD154) | ||||
R | 0.42 | 0.2 | 0.12 | 0.43 |
P value | 0.0003 | 0.0965 | 0.3141 | 0.0002 |
IL‐4 (Th2) polarization | ||||
R | 0.45 | 0.26 | 0.12 | 0.43 |
P value | <0.0001 | 0.0301 | 0.3378 | 0.0002 |
IFNγ responses (CD154) | ||||
R | −0.1 | −0.13 | 0.07 | −0.1 |
P value | 0.3952 | 0.2704 | 0.5647 | 0.398 |
IFNγ (Th1) polarization | ||||
R | −0.33 | −0.26 | −0.085 | −0.33 |
P value | 0.0044 | 0.0263 | 0.4784 | 0.0047 |
IL‐10 responses (CD154) | ||||
R | −0.18 | 13 | −0.00099 | −0.2 |
P value | 0.1328 | 0.2979 | 0.9935 | 0.096 |
IL‐10 polarization | ||||
R | −0.37 | −0.18 | −0.099 | −0.41 |
P value | 0.0013 | 0.1347 | 0.411 | 0.0003 |
Treg baseline numbers | ||||
R | −0.11 | −0.15 | −0.062 | −0.093 |
P value | 0.3729 | 0.2209 | 0.6047 | 0.4384 |
RU stands for relative units.
We next examined the correlation of T cell responses with the results of a skin prick test (SPT) specific for extracts of German and American CR, which share homologous allergens (www.allergen.org). As shown in Table S3, total responses or IL‐4 responses were positively but weakly correlated (p = 0.035; R = 0.25 and p = 0.042; R = 0.35, respectively), while IL‐10 polarization was negatively correlated (p = 0.015; R = −0.29) with the mean wheal diameter (MWD) of the SPT for the American CR extract. Conversely, none of the T cell variables correlated with MWD of the SPT for the German CR extract (Table S3). Despite differences in the source of the CR extract considered, these results confirm the associations noted at the serological level.
Lastly, we examined correlations of the T cell variables (magnitude, polarization, or dominance of specific allergens) with clinical variables such as those captured by Composite Asthma Severity Index (CASI) score and components. 34 As shown in Table S4, none of the T cell immunological variables correlate with the total CASI score. Also, no differences were observed in clinical symptoms between patients with IL‐4 or IFNγ dominant responses (Figure S7). These results were not unexpected given the fact that this cohort was designed to encompass relatively homogeneous CASI scores, ranging from low to medium severity (median CASI of 4).
4. DISCUSSION
Here we report the direct ex vivo characterization of T cell responses to a panel of 11 previously described CR allergens in a cohort of CR allergic children and adolescents with well‐controlled asthma. In particular, we found over 57‐fold variation in magnitude of allergen‐specific T cell responses. The more vigorous responses were also the most Th2 polarized and while the allergens Bla g 9 and Bla g 5 were most immunodominant, individual subjects exhibited distinctive patterns of allergen dominance. Subjects with higher magnitude of allergen‐specific T cell reactivity had lower number of Treg populations. Overall, this study unveils a surprisingly high level of heterogeneity in the pattern of Bla g‐specific T cell reactivity, both quantitatively and qualitatively. Since the cohort analyzed is enrolled in a future IT clinical trial, this finding lays the foundation for examining whether this heterogeneity may potentially correlate with IT outcomes.
This study is to the best of our knowledge, the first characterization of ex vivo CR‐specific CD4+ T cell responses in CR‐sensitized urban and under‐resourced children with asthma, and for the majority of the known CR allergens to date, which are also components commonly found in CR extracts used for IT. 2 , 10 Our results also differ from previous attempts of portrayal of CR‐specific responses, 17 , 19 , 20 because of the high level of granularity and because the ex vivo approach allowed to characterize responding cells to a minimal gap from bona fide in vivo responses.
We identified a large dynamic range in terms of magnitude of CD4+ T cell responses, despite the narrow age range and similar clinical manifestations of disease among participants. Positive controls included in each assay excluded that this was due to inter‐assay variability. The assessment of the variation of PBMC from the same subjects taken at different time points would have also been of great interest but limited by the number of existing cells available to perform the tests. Nevertheless, this should be considered in future study designs. Likewise, the variability was not explained by differential responses as a function of the different clinical sites from which each subject was enrolled. A high spread in the magnitude of T cell responses has been previously described for other allergic responses, namely to cat dander, fungus, mite and grass or birch pollen 30 , 46 , 47 using ex vivo methodologies similar to our study. It is possible that the ex vivo assay strategy utilized contributed to reveal this heterogeneity, as previous allergy studies in the case of CR 16 , 18 , 20 or other allergens 24 , 27 utilized in vitro restimulation protocols which might obscure and blunt differences.
We also analyzed the functionality of CD4+ T cell responses, which was dominated by IL‐4 production and a Th2 polarization profile. Development of early allergic disease seems to be related to sustained Th2‐skewed immunity during childhood 48 and previous studies have also demonstrated that levels of Th2 cytokines such as IL‐4, IL‐5, and IL‐13 are associated with pathogenesis of both allergy and asthma. 13 , 14 , 15 In our study, Th2 polarization was the dominant phenotype but other patterns were also observed. The accuracy of this characterization was confirmed with a positive control included in each assay. In particular, while IL‐10 responses were rare, a profile of IFNγ production or Th1 polarization was observed in one‐fourth of the participants and associated with weaker T cell CR‐specific responses. Also, since IFNγ is thought to be secreted in higher amounts per cell than IL‐4, perhaps the actual net amount of cytokine production might not necessarily correlate with the number of cytokine secreting cells as determined herein, but additional studies would be needed to clarify this conjecture. Interestingly, resolution of allergic‐related immunopathologies is often also attributed to increase of IFNγ levels rather than reduction of Th2‐cytokine production, 49 and IL‐10 is found to regulate CD4+ Th2 cells during allergic airway inflammation. 50 Therefore, the close monitoring of both IL‐10 and IFNγ cytokines would be of interest in the context of IT and could provide new clues for the association of baseline patterns of polarization or dominant allergens and IT outcomes.
Bla g 9 (arginine kinase) and Bla g 5 (glutathione‐S‐transferase) were the most immunodominant allergens. Interestingly, these enzymes are well conserved among arthropods or insects and have been shown to cross‐react with human IgE antibodies 51 , 52 and are often considered pan‐allergens and important players in the clinical manifestation of allergic sensitization. 53 Also, previous studies have reported Bla g 5 as a dominant T cell allergen 10 , 16 , 17 but patterns of allergen dominance could be associated with different forms of allergic disease. 17 These observations were made in adult cohorts, and this raises the possibility that Bla g 9 recognition could be a pattern predominantly associated with childhood CR allergy.
This pattern of immunodominance has been observed in subjects from the different clinical sites, irrespective of geographical location, further suggesting that Bla g 5 and Bla g 9 responses to CR are intrinsic to this particular age cohort. Changes in the IgE pattern of reactivity to individual Timothy grass and birch pollen allergens were observed over the course of 20 years for sensitized individuals. 54 Future studies could examine whether changes in allergen immunodominance are apparent as a function of age and exposure history.
The pattern of reactivity as a function of the specific subject considered was also heterogeneous with different individuals recognizing either Bla g 9 or Bla g 5 as dominant, with dominant responses to other allergens or no pattern of dominance also observed. Individual immunodominance patterns were observed in adult cohorts 16 and for IgE reactivity. 55 Different HLA could influence allergen immunodominance. Associations between CR sensitization and HLA class II antigens have been suggested 56 , 57 and consistently shown in food allergies. 58 , 59
In addition, we measured basal levels of non‐antigen specific regulatory T cells and observed that T cells inversely correlated with the effector CD4+ T cell responses although it did not reach statistical significance. These results were not unexpected and were consistent with previous observations from Bacher et al. 30 . The fact that the population of Treg cells varies amongst participants is also of potential interest, as this will enable monitoring of Treg and addressing whether baseline Treg levels predicts response to IT. A possible outcome is that IT may induce or enhance regulatory T cell function, which can be further tested. Indeed, peanut oral immunotherapy has been shown to increase antigen‐induced Treg function. 60
Overall, the current study reveals that in a pediatric cohort of CR‐sensitized subjects with mild‐to‐moderate asthma, subjects exhibit substantial heterogeneity in many key immunological parameters associated with CR‐specific T cell responses. We hypothesize that this large dynamic range of T cell reactivity may influence outcomes of allergen‐specific IT. These findings will also enable future research examining which of these parameters best predict the trajectory of evolution of allergic disease, and responsiveness to therapeutic intervention.
CONFLICT OF INTEREST
All authors declare no conflict of interest.
Supporting information
ACKNOWLEDGEMENTS
We wish to acknowledge all subjects for their participation and donate their blood and time for this study. The authors wish to thank all the personnel from the clinical sites involved in this work and Rho, particularly Amanda Farrell, Stephanie Wellford, Jessica Baucom, and Kelly Penke for their incessant efforts, supervision, and coordination. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under grants 1UM1AI114271‐01, UM2AI117870, and 5UM1AI114271‐03. Additional support was provided by the National Center for Research Resources, and National Center for Advancing Translational Sciences, National Institutes of Health, under grants NCATS/NIH UL1TR001079, NCATS/NIH UL1TR001422, NCATS/NIH UL1TR001876, NIH/CTSA 5UL1TR001425‐03, and NIAID/NIH U19AI135731. Dr. Lisa M. Wheatley and Alkis Togias co‐authorship of this publication does not necessarily constitute endorsement by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health or any other agency of the United States government.
da Silva Antunes R, Sutherland A, Frazier A, et al. Heterogeneity of magnitude, allergen immunodominance, and cytokine polarization of cockroach allergen‐specific T cell responses in allergic sensitized children. Clin Transl Allergy. 2021;e12073. doi:10.1002/clt2.12073
REFERENCES
- 1. Pomes A, Chapman MD, Wunschmann S. Indoor allergens and allergic respiratory disease. Curr Allergy Asthma Rep. 2016;16(6):43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Pomes A, Mueller GA, Randall TA, Chapman MD, Arruda LK. New insights into cockroach allergens. Curr Allergy Asthma Rep. 2017;17(4):25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Sohn MH, Kim KE. The cockroach and allergic diseases. Allergy Asthma Immunol Res. 2012;4(5):264‐269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner‐city children with asthma. N Engl J Med. 1997;336(19):1356‐1363. [DOI] [PubMed] [Google Scholar]
- 5. Do DC, Zhao Y, Gao P. Cockroach allergen exposure and risk of asthma. Allergy. 2016;71(4):463‐474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Gruchalla RS, Pongracic J, Plaut M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol. 2005;115(3):478‐485. [DOI] [PubMed] [Google Scholar]
- 7. Matsui EC, Wood RA, Rand C, et al. Cockroach allergen exposure and sensitization in suburban middle‐class children with asthma. J Allergy Clin Immunol. 2003;112(1):87‐92. [DOI] [PubMed] [Google Scholar]
- 8. Stelmach I, Jerzynska J, Stelmach W, et al. Cockroach allergy and exposure to cockroach allergen in Polish children with asthma. Allergy. 2002;57(8):701‐705. [DOI] [PubMed] [Google Scholar]
- 9. Chew GL, Perzanowski MS, Canfield SM, et al. Cockroach allergen levels and associations with cockroach‐specific IgE. J Allergy Clin Immunol. 2008;121(1):240‐245. [DOI] [PubMed] [Google Scholar]
- 10. Glesner J, Filep S, Vailes LD, et al. Allergen content in German cockroach extracts and sensitization profiles to a new expanded set of cockroach allergens determine in vitro extract potency for IgE reactivity. J Allergy Clin Immunol. 2019;143(4):1474‐1481. e1478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Pomes A, Glesner J, Calatroni A, et al. Cockroach allergen component analysis of children with or without asthma and rhinitis in an inner‐city birth cohort. J Allergy Clin Immunol. 2019;144(4):935‐944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Pongracic JA, Krouse RZ, Babineau DC, et al. Distinguishing characteristics of difficult‐to‐control asthma in inner‐city children and adolescents. J Allergy Clin Immunol. 2016;138(4):1030‐1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Ling MF, Luster AD. Allergen‐specific CD4(+) T cells in human asthma. Ann Am Thorac Soc. 2016;13(Suppl 1):S25‐S30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Romagnani S. Regulation of the development of type 2 T‐helper cells in allergy. Curr Opin Immunol. 1994;6(6):838‐846. [DOI] [PubMed] [Google Scholar]
- 15. Romagnani S. T‐cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol. 2001;1(1):73‐78. [DOI] [PubMed] [Google Scholar]
- 16. Birrueta G, Frazier A, Pomes A, et al. Variability in German cockroach extract composition greatly impacts T cell potency in cockroach‐allergic donors. Front Immunol. 2019;10:313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Dillon MB, Schulten V, Oseroff C, et al. Different Bla‐g T cell antigens dominate responses in asthma versus rhinitis subjects. Clin Exp Allergy. 2015;45(12):1856‐1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Oseroff C, Sidney J, Tripple V, et al. Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production. J Immunol. 2012;189(2):679‐688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Pomés P, Schulten V, Glesner J, et al. IgE and T Cell reactivity to a comprehensive panel of cockroach allergens in relation to disease. Front Immunol. 2021;11:3816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Schulten V, Frazier A, Calatroni A, et al. The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age. Clin Exp Allergy. 2019;49(8):1087‐1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Walters CS, Tackey RN, Reece E, Paluvoi S. Bystander T cells participate in specific response to cockroach antigen (CR) in vitro. Immunol Invest. 2003;32(1‐2):105‐118. [DOI] [PubMed] [Google Scholar]
- 22. Eckl‐Dorna J, Campana R, Valenta R, Niederberger V. Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay. Allergy. 2015;70(10):1222‐1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Gardner LM, O'Hehir RE, Rolland JM. High dose allergen stimulation of T cells from house dust mite‐allergic subjects induces expansion of IFN‐gamma+ T Cells, apoptosis of CD4+IL‐4+ T cells and T cell anergy. Int Arch Allergy Immunol. 2004;133(1):1‐13. [DOI] [PubMed] [Google Scholar]
- 24. Schulten V, Westernberg L, Birrueta G, et al. Allergen and epitope targets of mouse‐specific T cell responses in allergy and asthma. Front Immunol. 2018;9:235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Wambre E, James EA, Kwok WW. Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol. 2012;24(6):700‐706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Tian Y, da Silva Antunes R, Sidney J, et al. A review on T cell epitopes identified using prediction and cell‐mediated immune models for Mycobacterium tuberculosis and Bordetella pertussis. Front Immunol. 2018;9:2778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. da Silva Antunes R, Pham J, McMurtrey C, et al. Urinary peptides as a novel source of T cell allergen epitopes. Front Immunol. 2018;9:886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Grifoni A, da Silva Antunes R, Westernberg L, et al. Characterization and epitope identification of the T cell response in non‐allergic individuals exposed to mouse allergen. World Allergy Organ J. 2019;12(4):100026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Seumois G, Ramirez‐Suastegui C, Schmiedel BJ, et al. Single‐cell transcriptomic analysis of allergen‐specific T cells in allergy and asthma. Sci Immunol. 2020;5(48). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bacher P, Heinrich F, Stervbo U, et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell. 2016;167(4):1067‐1078. e1016. [DOI] [PubMed] [Google Scholar]
- 31. Cao H, Liu Z. Clinical significance of dust mite allergens. Mol Biol Rep. 2020;47(8):6239‐6246. [DOI] [PubMed] [Google Scholar]
- 32. Lei DK, Grammer LC. An overview of allergens. Allergy Asthma Proc. 2019;40(6):362‐365. [DOI] [PubMed] [Google Scholar]
- 33. Lopes MI, Miranda PJ, Sarinho E. Use of the skin prick test and specific immunoglobulin E for the diagnosis of cockroach allergy. J Pediatr (Rio J). 2006;82(3):204‐209. [DOI] [PubMed] [Google Scholar]
- 34. Wildfire JJ, Gergen PJ, Sorkness CA, et al. Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents. J Allergy Clin Immunol. 2012;129(3):694‐701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. da Silva Antunes R, Paul S, Sidney J, et al. Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect ex vivo tetanus CD4+ T cell responses. PLoS One. 2017;12(1):e0169086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Dan JM, Lindestam Arlehamn CS, Weiskopf D, et al. A cytokine‐independent approach to identify antigen‐specific human germinal center T follicular helper cells and rare antigen‐specific CD4+ T cells in blood. J Immunol. 2016;197(3):983‐993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Geginat J, Paroni M, Maglie S, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014;5:630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Yu N, Li X, Song W, et al. CD4(+)CD25 (+)CD127 (low/‐) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35(6):1773‐1780. [DOI] [PubMed] [Google Scholar]
- 39. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45‐56. [DOI] [PubMed] [Google Scholar]
- 40. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271‐282. [DOI] [PubMed] [Google Scholar]
- 41. da Silva Antunes R, Quiambao LG, Sutherland A, et al. Development and validation of a Bordetella pertussis whole‐genome screening strategy. J Immunol Res. 2020;2020:8202067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. da Silva Antunes R, Babor M, Carpenter C, et al. Th1/Th17 polarization persists following whole‐cell pertussis vaccination despite repeated acellular boosters. J Clin Invest. 2018;128(9):3853‐3865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. da Silva Antunes R, Quiambao LG, Soldevila F, Sutherland A, Peters B, Sette A. Lack of evidence supporting a role of IFN‐beta and TGF‐beta in differential polarization of Bordetella pertussis specific‐T cell responses. Cytokine. 2021;137:155313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Westernberg L, Schulten V, Greenbaum JA, et al. T‐cell epitope conservation across allergen species is a major determinant of immunogenicity. J Allergy Clin Immunol. 2016;138(2):571‐578. e577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Seddiki N, Santner‐Nanan B, Martinson J, et al. Expression of interleukin (IL)‐2 and IL‐7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203(7):1693‐1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Smith KA, Gray NJ, Cheek E, et al. Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers. BMC Immunol. 2013;14:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Smith KA, Gray NJ, Saleh F, et al. Characterisation of CD154+ T cells following ex vivo allergen stimulation illustrates distinct T cell responses to seasonal and perennial allergens in allergic and non‐allergic individuals. BMC Immunol. 2013;14:49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol. 2004;113(3):395‐400. [DOI] [PubMed] [Google Scholar]
- 49. Teixeira LK, Fonseca BP, Barboza BA, Viola JP. The role of interferon‐gamma on immune and allergic responses. Mem Inst Oswaldo Cruz. 2005;100(Suppl 1):137‐144. [DOI] [PubMed] [Google Scholar]
- 50. Coomes SM, Kannan Y, Pelly VS, et al. CD4(+) Th2 cells are directly regulated by IL‐10 during allergic airway inflammation. Mucosal Immunol. 2017;10(1):150‐161. [DOI] [PubMed] [Google Scholar]
- 51. Mattison CP, Tungtrongchitr A, Tille KS, Cottone CB, Riegel C. Cloning, expression, and immunological characterization of formosan subterranean termite (blattodea: rhinotermitidae) arginine kinase. J Insect Sci. 2020;20(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Sookrung N, Reamtong O, Poolphol R, et al. Glutathione S‐transferase (GST) of American cockroach, Periplaneta americana: classes, isoforms, and allergenicity. Sci Rep. 2018;8(1):484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Hauser M, Roulias A, Ferreira F, Egger M. Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol. 2010;6(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Moverare R, Kosunen TU, Haahtela T. Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20‐year period. J Investig Allergol Clin Immunol. 2006;16(5):274‐278. [PubMed] [Google Scholar]
- 55. Satinover SM, Reefer AJ, Pomes A, Chapman MD, Platts‐Mills TA, Woodfolk JA. Specific IgE and IgG antibody‐binding patterns to recombinant cockroach allergens. J Allergy Clin Immunol. 2005;115(4):803‐809. [DOI] [PubMed] [Google Scholar]
- 56. Donfack J, Tsalenko A, Hoki DM, et al. HLA‐DRB1*01 alleles are associated with sensitization to cockroach allergens. J Allergy Clin Immunol. 2000;105(5):960‐966. [DOI] [PubMed] [Google Scholar]
- 57. Kalpaklioglu AF, Turan M. Possible association between cockroach allergy and HLA class II antigens. Ann Allergy Asthma Immunol. 2002;89(2):155‐158. [DOI] [PubMed] [Google Scholar]
- 58. Hemler JA, Phillips EJ, Mallal SA, Kendall PL. The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Ann Allergy Asthma Immunol. 2015;115(6):471‐476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Kostara M, Chondrou V, Sgourou A, Douros K, Tsabouri S. HLA polymorphisms and food allergy predisposition. J Pediatr Genet. 2020;9(2):77‐86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Syed A, Garcia MA, Lyu SC, et al. Peanut oral immunotherapy results in increased antigen‐induced regulatory T‐cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol. 2014;133(2):500‐510. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.